# The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma

> **NCT00207805** · PHASE3 · COMPLETED · sponsor: **Centre National de Greffe de Moelle Osseuse** · enrollment: 202 (—)

## Conditions studied

- Multiple Myeloma

## Interventions

- **PROCEDURE:** autologous PBSC transplant

## Key facts

- **NCT ID:** NCT00207805
- **Lead sponsor:** Centre National de Greffe de Moelle Osseuse
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 202 (—)
- **Last updated:** 2009-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00207805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00207805, "The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00207805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*